53例女性肺移植受者妊娠结局分析
基于国际移植妊娠登记处(TPRI)1991至2021年的回顾性观察数据,53例女性肺移植受者报告了72次妊娠。活产率为62%,约60%的活产为早产和低出生体重。计划妊娠者的新生儿胎龄和出生体重更高,且受者死亡率更低,提示计划妊娠是 mitigating 风险的可干预因素。
要点
- 肺移植后妊娠活产率62%,但约60%的活产为早产且低出生体重。
- 计划妊娠者新生儿中位胎龄和出生体重均高于非计划妊娠者。
- 首次妊娠为非计划妊娠的受者生存率显著更低(HR 7.02)。
核心结论
- 肺移植后成功妊娠可行但母婴均存在风险,计划妊娠与更高的新生儿胎龄、出生体重及受者更低死亡率相关。
研究设计与样本
- 回顾性观察分析,纳入1991至2021年向国际移植妊娠登记处报告的53例肺移植后妊娠受者,共72次妊娠。
主要发现
- 移植主要适应证为囊性纤维化(60%)和肺动脉高压(19%)。
- 移植后避孕使用率为36%,54%的受者报告为非计划妊娠。
- 活产率为62%,共46例活产;约60%的活产为早产(<37周)且低出生体重(<2500g)。
- 7名儿童存在出生缺陷(16%),无一例为麦考酚酸(MPA)胚胎病;3例新生儿因极度早产死亡,其余43名儿童健康。
- 20例受者(38%)死亡,中位死亡时间为肺移植后23.6年;移植至受孕间隔≤2年与>2年者死亡率无差异(HR 1.26;95%CI 0.50-3.12;P=.625)。
临床怎么用
- 肺移植后应常规提供避孕咨询,因研究显示避孕使用率仅36%且非计划妊娠比例高。
- 建议肺移植受者计划妊娠,以降低早产、低出生体重及受者死亡风险。
局限性
- 回顾性观察设计,依赖登记处自愿报告,可能存在报告偏倚和未控制混杂因素。
- 样本量较小(53例受者,72次妊娠),部分分析效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited data exist to inform and appropriately counsel female lung transplant (LuT) recipients regarding pregnancy after transplantation. STUDY QUESTION: What are the modifiable factors that impact pregnancy outcomes in female LuT recipients? STUDY DESIGN AND METHODS: Retrospective observational analysis was performed on female LuT recipients who reported pregnancies after transplantation to the Transplant Pregnancy Registry International (TPRI). RESULTS: Fifty-three recipients who underwent LuT from 1991 through 2021 reported 72 pregnancies to TPRI. Predominant indications for transplant were cystic fibrosis (60%) and pulmonary hypertension (19%). Contraceptive use after transplantation was 36%. Most recipients (54%) reported unplanned pregnancies. The live birth rate was 62%, resulting in 46 live births. Approximately 60% of births were premature (< 37 weeks' gestational age [GA]) and of low birth weight (LBW) (< 2,500 g). Birth defects were seen in 7 children (16%), none with mycophenolic acid (MPA) embryopathy. Three neonatal deaths resulted from extreme prematurity; 43 remaining children are healthy. Twenty recipients (38%) have died a median of 23.6 years after LuT. Recipients with transplant-to-conception interval of ≤ 2 years had no difference in mortality compared with those with transplant-to-conception interval of > 2 years (hazard ratio [HR], 1.26; 95% CI, 0.50-3.12; P = .625). Recipients whose first pregnancy after transplantation was unplanned showed lower survival (HR, 7.02; 95% CI, 1.35-36.45; P = .020). Newborns of LuT recipients with planned vs unplanned pregnancies had higher median GA (36.9 weeks vs 34 weeks; P = .025) and birth weight (2,639 g vs 2,155 g; P = .047), and significantly lower risk of LBW for singletons (OR, 0.26; 95% CI, 0.07-0.94; P = .036). INTERPRETATION: Successful pregnancy after LuT is achievable, however, not without risks for mother and offspring. Our results showed that planned pregnancies resulted in higher GA and birth weight live births and showed lower mortality after pregnancy. TPRI data show 54% of recipients reported unplanned pregnancies, an obvious area for improvement. Planning pregnancy is the most modifiable factor for mitigating risks.
引用
- Lee FG, Coscia LA, Constantinescu S, et al. Pregnancy Outcomes in 53 Female Lung Transplant Recipients. Chest. 2025. PMID: 40350146. doi:10.1016/j.chest.2025.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。